• Food Science and Biotechnology
• /
• 제14권6호
• /
• pp.766-771
• /
• 2005

We evaluated the effects of newly developed functional food containing Bacillus polyfermenticus SCD as the main material on the lipid and antioxidant metabolisms of hypercholesterolemic rats. Thirty male SD rats were divided into three groups after a 1-week adaptation period and were fed with a high fat-cholesterol diet (control), or with a high fat-cholesterol diet supplemented with low or high doses ($3.1\;{\times}\;10^6\;cfu/day$ or $3.1\;{\times}\;10^8\;cfu/day$) of B. polyfermenticus SCD and other physiological active materials for 6 weeks. Both doses of B. polyfermenticus SCD significantly reduced hepatic total cholesterol and triglycerides, while increasing the fecal excretion rates of total lipid, total cholesterol and triglycerides. B. polyfermenticus SCD increased the total radical trapping antioxidant potential (TRAP). The erythrocytic glutathione peroxidase activity in the B. polyfermenticus groups was significantly lower than that in the control group. Plasma TRAP levels exhibited a highly significant negative correlation with hepatic total cholesterol while a significant positive correlation was detected between fecal total cholesterol and plasma TRAP. This hypolipidemic and antioxidative effect of B. polyfermenticus SCD seemed to be unrelated to its dosage. These results suggest that functional food containing B. polyfermenticus SCD can improve oxidative stress and hepatic lipid profiles by enhancing the excretion of cholesterol and triglycerides in feces of rats fed with high fat-high cholesterol diet.

• Nutrition Research and Practice
• /
• 제7권4호
• /
• pp.287-293
• /
• 2013

This study determined the effects of fucoxanthin on gene expressions related to lipid metabolism in rats with a high-fat diet. Rats were fed with normal fat diet (NF, 7% fat) group, high fat diet group (HF, 20% fat), and high fat with 0.2% fucoxanthin diet group (HF+Fxn) for 4 weeks. Body weight changes and lipid profiles in plasma, liver, and feces were determined. The mRNA expressions of transcriptional factors such as sterol regulatory element binding protein (SREBP)-1c, Carnitine palmitoyltransferase-1 (CPT1), Cholesterol $7{\alpha}$-hydroxylase1 (CYP7A1) as well as mRNA expression of several lipogenic enzymes were determined. Fucoxanthin supplements significantly increased plasma high density lipoprotein (HDL) concentration (P < 0.05). The hepatic total lipids, total cholesterols, and triglycerides were significantly decreased while the fecal excretions of total lipids, cholesterol, and triglycerides were significantly increased in HF+Fxn group (P < 0.05). The mRNA expression of hepatic Acetyl-CoA carboxylase (ACC), Fatty acid synthase (FAS), and Glucose-6-phosphate dehydrogenase (G6PDH) as well as SREBP-1C were significantly lower in HF+Fxn group compared to the HF group (P < 0.05). The hepatic mRNA expression of Hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) and Acyl-CoA cholesterol acyltransferase (ACAT) were significantly low while lecithin-cholesterol acyltransferase (LCAT) was significantly high in the HF+Fxn group (P < 0.05). There was significant increase in mRNA expression of CPT1 and CYP7A1 in the HF+Fxn group, compared to the HF group (P < 0.05). In conclusion, consumption of fucoxanthin is thought to be effective in improving lipid and cholesterol metabolism in rats with a high fat diet.

• 한국식품과학회지
• /
• 제41권2호
• /
• pp.191-195
• /
• 2009

본 연구는 새송이 버섯을 첨가하여 만든 어묵이 체내 지질 대사와 효소 활성에 미치는 영향을 알아보고자 수컷 Sprague-Dawley 흰쥐 30마리를 대상으로 고콜레스테롤(1%)첨가 기본식이, 30% 일반어묵 첨가 식이와 40% 새송이 버섯 첨가 오징어 어묵 식이를 급여하였다. 평균 식이 섭취량은 대조군, 일반 어묵군, 새송이 버섯 첨가 오징어 어묵군에 따른 각 군 간의 유의적인 차이는 볼 수 없었다. 체중 증가량과 식이효율은 대조군에 비해 실험군 모두 유의적으로 감소하는 경향을 보였다. 혈장 중성지질과 총 콜레스테롤, 동맥경화지수(A.I), GOT, GPT 수준은 대조군이 새송이 버섯 첨가 오징어 어묵군에 비해 유의적으로 높게 나타났다. HDL-콜레스테롤의 경우 새송이 버섯 첨가 오징어 어묵군이 대조군과 일반 어묵군보다 낮게 나타났고, 간조직의 콜레스테롤 및 중성 지방 농도는 유의적으로 차이가 없는 것으로 나타났다. 혈장과 간조직 TBARS 수준은 대조군보다 새송이 버섯 첨가 오징어 어묵군에서 유의적으로 낮은 수치를 보였다. 항산화 효소 활성도에서 SOD활성도는 대조군과 일반 어묵과의 유의적인 차이가 없었으며, CAT활성도는 대조군보다 새송이 버섯 첨가 어묵이 유의적으로 높게 나타났으며. GPx활성도 역시 유의적으로 높게 나타났다. 이 결과들을 종합해 보면, 고콜레스테롤혈증 흰쥐에서의 새송이 버섯 첨가 오징어 어묵은 전반적인 지질대사 개선과 함께 SOD, CAT, GPx와 같은 항산화 효소의 활성을 증가시켜 항산화 방어계에도 긍정적인 효과를 나타냄으로써 앞으로 고콜레스테롤 혈증 예방 등의 혈관 순환기 계통 질병을 예방하기 위한 식품으로써의 활용이 기대된다.

• 한국영양학회:학술대회논문집
• /
• 한국영양학회 2002년도 추계학술대회 및 총회
• /
• pp.149-149
• /
• 2002

• 한국식품영양과학회지
• /
• 제42권7호
• /
• pp.1043-1053
• /
• 2013

본 연구에서는 대두가공부산물의 하나인 비지(SCR: soybean crud residue)를 이용하여 만든 메주를 항비만 또는 혈중지질 개선용의 식 의약 소재로써의 직접적인 이용 가능성을 검토할 목적으로 우리나라의 전통메주 발효의 주요 미생물의 하나인 Aspergillus oryzae var effuses KACC 44990로 발효시킨 메주(ASCR)와 홍국 제조용으로 사용되는 미생물의 하나인 Monascus pilosus IFO 4480으로 발효시킨 메주(MSCR) 및 이들을 1:1(w/w)로 상호 혼합한 메주(AMSCR)를 제조하였으며 이들 메주를 각 2%씩 함유하는 고지방식이로 8주간 마우스를 사육하였을 때의 체중, 혈액 및 간 조직 지질의 함량 변동과 간 조직 ROS 생성계 및 소거계 효소의 활성을 측정하였다. SCR, ASCR, MSCR 및 AMSCR은 고지방식이 또는 비만으로 유도된 간, 심장, 신장, 고환의 비대 현상과 부고환 주변 지방의 함량을 감소시키는 효과가 있으며, 그 효과는 AMSCR>ASCR>MSCR>SCR 순으로 ASCR과 AMSCR에서 높았다. SCR, ASCR, MSCR 및 AMSCR은 고지방식이 또는 비만으로 유도된 혈청과 간조직의 중성지방과 총콜레스테롤 함량을 감소시키는 효과가 있으며, 혈청의 HDL 콜레스테롤 함량을 높이면서 LDL 콜레스테롤 함량을 낮추는 효과가 있다. 특히 ASCR은 중성지방의 함량을, 그리고 MSCR은 콜레스테롤의 함량을 각각 감소시키는 효과가 높으며, ASCR과 MSCR을 혼합한 AMSCR에서 종합적인 지질개선 효과가 높았다. SCR, ASCR, MSCR 및 AMSCR은 고지방식이 또는 비만상태에서 나타나는 간 손상을 예방하는 효과가 있으며 그 효과는 AMSCR>ASCR>MSCR>SCR 순으로 컸다. SCR, ASCR, MSCR 및 AMSCR은 고지방식이 또는 비만상태에서 나타나는 ROS 생성계 효소인 XO의 활성을 억제시킴과 동시에 ROS 소거계 효소인 SOD, GPX 및 GST의 활성을 높이는 효과가 있으며 그 효과는 AMSCR>ASCR>MSCR>SCR 순으로 컸다. 결론적으로 본 실험을 통하여 발효비지는 항비만 효과가 있을 뿐만 아니라 지질을 개선할 수 있음을 확인하였다.

• Nutrition Research and Practice
• /
• 제7권6호
• /
• pp.481-487
• /
• 2013

High-fat diet up-regulates either insulin resistance or triglycerides, which is assumed to be related to the expression of peroxisome proliferator-activated receptor (PPAR)-${\alpha}$ and PPAR-${\gamma}$. The beneficial effects of vitamin E on insulin resistance are well known; however, it is not clear if vitamin E with a high-fat diet alters the expression of PPAR-${\alpha}$ and PPAR-${\gamma}$. We investigated the effects of d-${\alpha}$-tocopherol supplementation on insulin sensitivity, blood lipid profiles, lipid peroxidation, and the expression of PPAR-${\alpha}$ and PPAR-${\gamma}$ in a high-fat (HF) diet-fed male C57BL/6J model of insulin resistance. The animals were given a regular diet (CON; 10% fat), a HF diet containing 45% fat, or a HF diet plus d-${\alpha}$-tocopherol (HF-E) for a period of 20 weeks. The results showed that the HF diet induced insulin resistance and altered the lipid profile, specifically the triglyceride (TG) and total cholesterol (TC) levels (P < 0.05). In this animal model, supplementation with d-${\alpha}$-tocopherol improved insulin resistance as well as the serum levels of TG and very-low-density lipoprotein-cholesterol (VLDL-C) (P < 0.05). Moreover, the treatment decreased the levels of malondialdehyde (MDA) in the serum and liver while increasing hepatic PPAR-${\alpha}$ expression and decreasing PPAR-${\gamma}$ expression. In conclusion, the oral administration of d-${\alpha}$-tocopherol with a high-fat diet had positive effects on insulin resistance, lipid profiles, and oxidative stress through the expression of PPAR-${\alpha}$ and PPAR-${\gamma}$ in a high-fat diet-fed male mice.

• 한국동물위생학회지
• /
• 제38권2호
• /
• pp.117-125
• /
• 2015

This study was investigated the effects on the radical scavenging activities and hepatic lipid levels in rats fed a high-fat diet (HFD) by the 70% ethanolic extract from Rubus coreanus. The Rubus coreanus extract (RCE) was administered through the gastrointestinal tract at 150 mg/kg BW/day for 5 weeks (HFD+RCE). Total phenol content was 157.93 mg gallic acid/g in the RCE. Scavenging activities to DPPH, ABTS, an d hydroxyl radicals by RCE significantly increased in a does-dependent manner of $50{\sim}500{\mu}g/mL$ concentration. DPPH and ABTS radical scavenging activities were over the 70% in the $500{\mu}g/mL$ concentration. During the five weeks study, the food efficiency ratio was no significant differences between the HFD and HFD+RCE. Liver weight of HFD+RCE (3.75 g/100 g BW) was significantly decreased compared to those of the HFD. Hepatic triglyceride and total cholesterol levels of HFD+RCE were significantly lower compared to those of the HFD. The hepatic TBARS contents in the HFD+RCE was significantly decreased to the HFD, radical scavenging activity was markedly increased in HFD+RCE as normal group. In histological observation of liver tissues, the hepatocytes of HFD+RCE appeared the reduced aspects on the size and numbers of lipid droplets in cytoplasm compared to the HFD. Our results suggest that RCE could have antioxidant activities and hepatic hypolipidemic effects by its phenolic compounds.

• Mycobiology
• /
• 제39권1호
• /
• pp.45-51
• /
• 2011

This work was conducted to investigate dietary supplementation of oyster mushroom fruiting bodies on biochemical and histological changes in hyper and normocholesterolemic rats. Six-week old female Sprague-Dawley albino rats were divided into three groups of 10 rats each. Feeding a diet containing a 5% powder of Pleurotus ostreatus fruiting bodies to hypercholesterolemic rats reduced plasma total cholesterol, triglyceride, low-density lipoprotein (LDL), total lipid, phospholipids, and LDL/high-density lipoprotein ratio by 30.18, 52.75, 59.62, 34.15, 23.89, and 50%, respectively. Feeding oyster mushrooms also significantly reduced body weight in hypercholesterolemic rats. However, it had no adverse effects on plasma albumin, total bilirubin, direct bilirubin, creatinin, blood urea nitrogen, uric acid, glucose, total protein, calcium, sodium, potassium, chloride, inorganic phosphate, magnesium, or enzyme profiles. Feeding mushroom increased total lipid and cholesterol excretion in feces. The plasma lipoprotein fraction, separated by agarose gel electrophoresis, indicated that P. ostreatus significantly reduced plasma ${\beta}$ and pre-${\beta}$-lipoprotein but increased ${\alpha}$-lipoprotein. A histological study of hepatic cells by conventional hematoxylin-eosin and oil red O staining revealed normal findings for mushroom-fed hypercholesterolemic rats. These results suggest that a 5% P. ostreatus diet supplement provided health benefits by acting on the atherogenic lipid profile in hypercholesterolemic rats.

• Molecular & Cellular Toxicology
• /
• 제3권1호
• /
• pp.60-67
• /
• 2007

Gentamicin is a broad-spectrum aminoglycoside antibiotic used in the treatment of bacterial infection. Although side effects of gentamicin such as nephrotoxicity and ototoxicity have been investigated, the information on the hepatic effects of gentamicin is still limited. In the present study, gene expression profiles were analyzed in the liver of gentamicin treated mice using Affymetrix GeneChip$^{(R)}$ Mouse Expression 430A 2.0 Array. Totally, 400 genes were identified as being either up- or down-regulated over 1.5-fold changes (P<0.01) in the liver of gentamicin treated mice. Among these deregulated genes, 16 up-regulated genes mainly involved in transport (Kif5b, Pex14, Rab14, Clcn3, and Necap1) and 20 down-regulated genes involved in lipid and other metabolisms (Hdlbp, Gm2a, Uroc1, and Dak) were selected using k-means clustering algorithm. The functional classification of differentially expressed genes represented that several stress-related genes were regulated in the liver by gentamicin treatment. This data may contribute in understanding the molecular mechanism in the liver of gentamicin treated mice.

• Journal of Microbiology and Biotechnology
• /
• 제33권10호
• /
• pp.1351-1360
• /
• 2023

Endocrine-disrupting chemicals (EDCs) are compounds that disturb hormonal homeostasis by binding to receptors. EDCs are metabolized through hepatic enzymes, causing altered transcriptional activities of hormone receptors, and thus necessitating the exploration of the potential endocrine-disrupting activities of EDC-derived metabolites. Accordingly, we have developed an integrative workflow for evaluating the post-metabolic activity of potential hazardous compounds. The system facilitates the identification of metabolites that exert hormonal disruption through the integrative application of an MS/MS similarity network and predictive biotransformation based on known hepatic enzymatic reactions. As proof-of-concept, the transcriptional activities of 13 chemicals were evaluated by applying the in vitro metabolic module (S9 fraction). Identified among the tested chemicals were three thyroid hormone receptor (THR) agonistic compounds that showed increased transcriptional activities after phase I+II reactions (T3, 309.1 ± 17.3%; DITPA, 30.7 ± 1.8%; GC-1, 160.6 ± 8.6% to the corresponding parents). The metabolic profiles of these three compounds showed common biotransformation patterns, particularly in the phase II reactions (glucuronide conjugation, sulfation, GSH conjugation, and amino acid conjugation). Data-dependent exploration based on molecular network analysis of T3 profiles revealed that lipids and lipid-like molecules were the most enriched biotransformants. The subsequent subnetwork analysis proposed 14 additional features, including T4 in addition to 9 metabolized compounds that were annotated by prediction system based on possible hepatic enzymatic reaction. The other 10 THR agonistic negative compounds showed unique biotransformation patterns according to structural commonality, which corresponded to previous in vivo studies. Our evaluation system demonstrated highly predictive and accurate performance in determining the potential thyroid-disrupting activity of EDC-derived metabolites and for proposing novel biotransformants.